Patents by Inventor Benjamin Larimer

Benjamin Larimer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Granzyme B Directed Imaging and Therapy
    Publication number: 20230338588
    Abstract: Provided herein are compounds useful for imaging granzyme B. An exemplary compound provided herein is useful as a radiotracer for position emission tomography (PET) and/or single photon emission tomography (SPECT) imaging. Methods of imaging granzyme B, combination therapies, and kits comprising the granzyme B imaging agents are also provided.
    Type: Application
    Filed: January 5, 2023
    Publication date: October 26, 2023
    Inventors: Umar Mahmood, Benjamin Larimer, Eric Wehrenberg-Klee
  • Granzyme B directed imaging and therapy
    Patent number: 11559590
    Abstract: Provided herein are compounds useful for imaging granzyme B. An exemplary compound provided herein is useful as a radiotracer for position emission tomography (PET) and/or single photon emission tomography (SPECT) imaging. Methods of imaging granzyme B, combination therapies, and kits comprising the granzyme B imaging agents are also provided.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: January 24, 2023
    Assignee: The General Hospital Corporation
    Inventors: Umar Mahmood, Benjamin Larimer, Eric Wehrenberg-Klee
  • HER3 Peptides for Imaging and Radiotherapy
    Publication number: 20220175975
    Abstract: Provided herein are compositions useful for imaging HER3. An exemplary composition provided herein is useful as a radiotracer for position emission tomography (PET) imaging. Methods of imaging HER3 and combination therapies comprising the HER3 imaging agents are also provided.
    Type: Application
    Filed: December 27, 2021
    Publication date: June 9, 2022
    Inventors: Umar Mahmood, Benjamin Larimer
  • HER3 peptides for imaging and radiotherapy
    Patent number: 11241511
    Abstract: Provided herein are compositions useful for imaging HER3. An exemplary composition provided herein is useful as a radiotracer for position emission tomography (PET) imaging. Methods of imaging HER3 and combination therapies comprising the HER3 imaging agents are also provided.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: February 8, 2022
    Assignee: The General Hospital Corporation
    Inventors: Umar Mahmood, Benjamin Larimer
  • HER3 Peptides for Imaging and Radiotherapy
    Publication number: 20200121814
    Abstract: Provided herein are compositions useful for imaging HER3. An exemplary composition provided herein is useful as a radiotracer for position emission tomography (PET) imaging. Methods of imaging HER3 and combination therapies comprising the HER3 imaging agents are also provided.
    Type: Application
    Filed: December 29, 2017
    Publication date: April 23, 2020
    Inventors: Umar Mahmood, Benjamin Larimer
  • Granzyme B Directed Imaging and Therapy
    Publication number: 20190224348
    Abstract: Provided herein are compounds useful for imaging granzyme B. An exemplary compound provided herein is useful as a radiotracer for position emission tomography (PET) and/or single photon emission tomography (SPECT) imaging. Methods of imaging granzyme B, combination therapies, and kits comprising the granzyme B imaging agents are also provided.
    Type: Application
    Filed: June 30, 2017
    Publication date: July 25, 2019
    Inventors: Umar Mahmood, Benjamin Larimer, Eric Wehrenberg-Klee